Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Targeting novel mechanisms of pain in sickle cell disease.

Tran H, Gupta M, Gupta K.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):546-555. doi: 10.1182/asheducation-2017.1.546. Review.

PMID:
29222304
2.

Targeting novel mechanisms of pain in sickle cell disease.

Tran H, Gupta M, Gupta K.

Blood. 2017 Nov 30;130(22):2377-2385. doi: 10.1182/blood-2017-05-782003. Review.

PMID:
29187376
3.

Mouse Models of Pain in Sickle Cell Disease.

Sagi V, Song-Naba WL, Benson BA, Joshi SS, Gupta K.

Curr Protoc Neurosci. 2018 Oct;85(1):e54. doi: 10.1002/cpns.54. Epub 2018 Sep 28.

PMID:
30265442
4.

State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Puri L, Nottage KA, Hankins JS, Anghelescu DL.

Paediatr Drugs. 2018 Feb;20(1):29-42. doi: 10.1007/s40272-017-0263-z. Review.

PMID:
28853040
5.

Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.

De Franceschi L, Mura P, Schweiger V, Vencato E, Quaglia FM, Delmonte L, Evangelista M, Polati E, Olivieri O, Finco G.

Pain Pract. 2016 Jul;16(6):680-7. doi: 10.1111/papr.12313. Epub 2015 May 26.

PMID:
26009799
6.

Thinking beyond sickling to better understand pain in sickle cell disease.

Darbari DS, Ballas SK, Clauw DJ.

Eur J Haematol. 2014 Aug;93(2):89-95. doi: 10.1111/ejh.12340. Epub 2014 May 16. Review.

7.

Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.

Darbari DS, Hampson JP, Ichesco E, Kadom N, Vezina G, Evangelou I, Clauw DJ, Taylor Vi JG, Harris RE.

J Pain. 2015 Nov;16(11):1077-86. doi: 10.1016/j.jpain.2015.07.005. Epub 2015 Aug 18.

8.

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.

Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ; CURAMA Study Group.

Am J Hematol. 2011 Jun;86(6):484-9. doi: 10.1002/ajh.22012. Epub 2011 May 4. Review.

9.

Targeting pain at its source in sickle cell disease.

Gupta K, Jahagirdar O, Gupta K.

Am J Physiol Regul Integr Comp Physiol. 2018 Jul 1;315(1):R104-R112. doi: 10.1152/ajpregu.00021.2018. Epub 2018 Mar 28.

PMID:
29590553
10.

Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.

Allen Liles E, Kirsch J, Gilchrist M, Adem M.

Hosp Pract (1995). 2014 Apr;42(2):70-6. doi: 10.3810/hp.2014.04.1105.

PMID:
24769786
11.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
12.

Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Khaleel M, Puliyel M, Shah P, Sunwoo J, Kato RM, Chalacheva P, Thuptimdang W, Detterich J, Wood JC, Tsao J, Zeltzer L, Sposto R, Khoo MCK, Coates TD.

Am J Hematol. 2017 Nov;92(11):1137-1145. doi: 10.1002/ajh.24858. Epub 2017 Aug 17.

13.

Sickle cell disease pain management in adolescents: a literature review.

Wilson BH, Nelson J.

Pain Manag Nurs. 2015 Apr;16(2):146-51. doi: 10.1016/j.pmn.2014.05.015. Epub 2014 Aug 28. Review.

PMID:
25175555
14.

Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.

Baddam S, Aban I, Hilliard L, Howard T, Askenazi D, Lebensburger JD.

Pediatr Nephrol. 2017 Aug;32(8):1451-1456. doi: 10.1007/s00467-017-3623-6. Epub 2017 Feb 25.

15.

Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.

Sins JWR, Schimmel M, Luken BM, Nur E, Zeerleder SS, van Tuijn CFJ, Brandjes DPM, Kopatz WF, Urbanus RT, Meijers JCM, Biemond BJ, Fijnvandraat K.

J Thromb Haemost. 2017 Jul;15(7):1392-1402. doi: 10.1111/jth.13728. Epub 2017 Jun 5.

PMID:
28457019
16.

Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain.

Hebbel RP.

Hematol Oncol Clin North Am. 2014 Apr;28(2):181-98. doi: 10.1016/j.hoc.2013.11.005. Review.

PMID:
24589261
17.

Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Zhang D, Xu C, Manwani D, Frenette PS.

Blood. 2016 Feb 18;127(7):801-9. doi: 10.1182/blood-2015-09-618538. Epub 2016 Jan 12. Review.

18.

Leukotriene pathway in sickle cell disease: a potential target for directed therapy.

Knight-Perry J, DeBaun MR, Strunk RC, Field JJ.

Expert Rev Hematol. 2009 Feb;2(1):57-68. doi: 10.1586/17474086.2.1.57. Review.

PMID:
21082995
19.

Emerging biobehavioral factors of fatigue in sickle cell disease.

Ameringer S, Smith WR.

J Nurs Scholarsh. 2011 Mar;43(1):22-9. doi: 10.1111/j.1547-5069.2010.01376.x. Epub 2011 Jan 4. Review.

20.

Sickle cell disease pain management and the medical home.

Raphael JL, Oyeku SO.

Hematology Am Soc Hematol Educ Program. 2013;2013:433-8. doi: 10.1182/asheducation-2013.1.433. Review.

PMID:
24319216

Supplemental Content

Support Center